ESR1 and oropharynx cancer: Koenigs et al. concluded that ER positivity in HPV-positive oropharyngeal cancers was associated with improved mortality on a general, disease-specific, progression-free, and relapse-free basis; statistically significant associations were maintained when clinical risks were adjusted, including the HPV status of the individual [13].